8-K/A filed September 10, 2026, 4:55 PM ET ticker AXGN CIK 0000805928

M&A confidence low sentiment neutral materiality 0.60

Axogen files merger agreement with BioCircuit Technologies; terms not disclosed

Axogen, Inc.

Axogen entered into a merger agreement with BioCircuit Technologies on September 9, 2026, with Omega Merger Sub as merger sub.
Agreement filed as Exhibit 2.1; Michelle Jarrard named representative for BioCircuit equityholders.
Corrected investor presentation dated September 10, 2026 furnished as Exhibit 99.2.
No deal value, premium, or closing conditions disclosed in the filing text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.